VAERS reports by lot

GSK DTaP/Tdap lot 49TM3: VAERS reports

49 VAERS reports list lot 49TM3 as a GSK DTaP/Tdap vaccine, received between 2020-10-08 and 2022-08-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
49
Reports
0%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2753%
General / Systemic (non-local)816%
Gastrointestinal612%
Psychiatric / Neuropsychiatric36%
Neurological24%
Allergic / Anaphylactic24%
Cardiac / Cardiovascular12%
Musculoskeletal12%
Dermatological (non-injection-site)12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan8
Texas3
Nevada3
Arizona3
Utah2
Colorado2
Wisconsin2
Arkansas2
Virginia2
Pennsylvania2
New York2
Tennessee1

Reports by month received

2020-104
2020-112
2021-014
2021-023
2021-031
2021-046
2021-053
2021-061
2021-074
2021-083
2021-091
2021-105
2021-121
2022-021
2022-068
2022-071
2022-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.